Rashid G, Ophir R, Pecht M, Ben-Efraim S
Department of Human Microbiology, Sackler School of Medicine, Tel Aviv University, Israel.
In Vivo. 1989 Jul-Aug;3(4):279-84.
The immunocompetence status of mice bearing MOPC-315 plasmacytoma was determined at various days after tumor inoculation. Changes in T and B-cell functions appeared gradually. The allogeneic response of spleen cells from BALB/c tumor-bearing mice against C57BL spleen cells was impaired from the 4th day after the tumor inoculation (nonpalpable tumor stage). The primary antibody response in vitro against SRBC was depressed at 18 days, and the mitogenic response of splenic cells to PHA and to LPS was depressed at 25 days after the tumor inoculation. T cells taken from day 18 tumor-bearing mice partially suppressed the MLR response of normal splenocytes. Mice bearing large MOPC-315 tumors responded less to SRBC immunization than normal, noninoculated mice. The relative percentage of Lyt 1, Lyt 2 and L3T4 T-cell subsets decreased starting from the 11th day after tumor inoculation.
在接种肿瘤后的不同天数测定携带MOPC - 315浆细胞瘤小鼠的免疫能力状态。T细胞和B细胞功能的变化逐渐出现。接种肿瘤后第4天(肿瘤不可触及阶段),BALB/c荷瘤小鼠脾细胞对C57BL脾细胞的同种异体反应受损。接种肿瘤后18天,体外对SRBC的初次抗体反应受到抑制,接种肿瘤后25天,脾细胞对PHA和LPS的促有丝分裂反应受到抑制。取自接种肿瘤18天小鼠的T细胞部分抑制了正常脾细胞的混合淋巴细胞反应。携带大的MOPC - 315肿瘤的小鼠对SRBC免疫的反应比正常未接种小鼠弱。从接种肿瘤后第11天开始,Lyt 1、Lyt 2和L3T4 T细胞亚群的相对百分比下降。